Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is OMEPRAZOLE USP, with a corresponding US DMF Number 26796.
Remarkably, this DMF maintains an Active status since its submission on March 14, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 09, 2013, and payment made on February 26, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II